ArticleInternational journal of oncology2017

Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative.

Vishnu Muthuraj Kumarasamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.